Evidence map›Paper›PMID 26400483›Full record

ArticleDiagnostic pathology2015

p16INK4A expression is frequently increased in periorbital and ocular squamous lesions.

Peter J Kobalka, Jean-Paul Abboud, Xiaoyan Liao, Karra Jones, Bradford W Lee, Bobby S Korn, Don O Kikkawa, Jonathan H Lin

Open access · goldAbstract read
In one paragraph

Article in Diagnostic pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Peter J KobalkaDepartment of Pathology, University of California San Diego and VA San Diego Healthcare System, San Diego, CA, USA. pkobalka@ucsd.edu.
Jean-Paul AbboudShiley Eye Center and Department of Ophthalmology, University of California San Diego and VA San Diego Healthcare System, San Diego, CA, USA. jabboud@ucsd.edu.
Xiaoyan LiaoDepartment of Pathology, University of California San Diego and VA San Diego Healthcare System, San Diego, CA, USA. x1liao@ucsd.edu.
Karra JonesDepartment of Pathology, University of California San Diego and VA San Diego Healthcare System, San Diego, CA, USA. kaj014@ucsd.ed.
Bradford W LeeShiley Eye Center and Department of Ophthalmology, University of California San Diego and VA San Diego Healthcare System, San Diego, CA, USA. bwl010@ucsd.edu.
Bobby S KornShiley Eye Center and Department of Ophthalmology, University of California San Diego and VA San Diego Healthcare System, San Diego, CA, USA. bkorn@ucsd.edu.
Don O KikkawaShiley Eye Center and Department of Ophthalmology, University of California San Diego and VA San Diego Healthcare System, San Diego, CA, USA. dkikkawa@ucsd.edu.
Jonathan H LinDepartment of Pathology, University of California San Diego and VA San Diego Healthcare System, San Diego, CA, USA. jlin@ucsd.edu.
University of California, San Diego · USVA San Diego Healthcare System · US

Funding

Cellular and Molecular Mechanisms of Age-Related Retinal DegenerationI01BX002284 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI LIN, JONATHAN · 2014 to 2023
–
BLRD VA I01 BX002284
6 · The paper itself

Abstract

backgroundp16 expression is a well established biomarker of cervical dysplasia and carcinoma arising from high risk human papilloma virus infection. Increased p16 expression is also seen in squamous neoplasms arising at other sites, including head, neck, and oropharyngeal tract. Squamous lesions are also frequently encountered at ocular surface and peri-orbital skin sites, but the prevalence of increased p16 expression in these lesions has been poorly studied.

methodsWe retrospectively surveyed 13 ocular surface and 16 orbital squamous lesions biopsied at UC San Diego Healthcare System and VA San Diego Healthcare System for p16 expression by immunohistochemistry. These cases included ocular surface lesions with diagnoses of conjunctival intraepithelial neoplasm (CIN) and squamous cell carcinoma in situ. Peri-orbital eyelid biopsies included lesions with diagnoses of SCCis and invasive squamous cell carcinoma. We performed multivariate logistic regression, followed by student's T-test or Fisher's exact test to determine if there were statistically significant associations between p16 immunoreactivity and patient age, gender, diagnosis, and ethnicity. Statistical significance was defined as p < 0.05.

resultsWe found an unexpectedly large prevalence of strong nuclear and cytoplasmic p16 immunoreactivity in our cases. Almost all of the ocular surface squamous lesions were diffusely positive for p16 expression (12/13). All of the periorbital lesions showed diffuse p16 immunoreactivity (16/16). Altogether, 28/29 lesions tested showed strong and diffuse p16 expression. We found no statistically significant correlation between p16 expression and patient age, gender, ethnicity, or diagnosis. In 6 of the peri-orbital biopsies, we had sufficient tissue to assess high-risk HPV expression by in situ hybridization. Interestingly, all of these cases were negative for HPV, despite strong p16 expression.

conclusionStrong p16 expression was observed in virtually all of the ocular surface and peri-orbital squamous neoplasms in our study. The relationship between p16 expression and HPV infection in ocular surface and peri-orbital sites requires further investigation.

Indexed as

AdultAgedAged, 80 and overBiomarkers, TumorCarcinoma, Squamous CellEye NeoplasmsFemaleGene Expression Regulation, NeoplasticGenes, p16HumansMaleMiddle AgedRetrospective StudiesBiomarkers, Tumor

Identifiers

PMID26400483
PMCPMC4581440
OpenAlexW1925328971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.